Biosimilars, a rapidly evolving field in biopharmaceutics, represent a groundbreaking category of therapeutic agents. These biological products, akin to existing biologics, are designed to demonstrate comparable efficacy, safety, and quality. Unlike generic drugs, biosimilars are complex and intricately manufactured, often involving living organisms.
The development of biosimilars is a result of advancements in biotechnology, allowing for the replication of intricate structures found in biopharmaceuticals. These products not only expand patient access to life-changing treatments but also contribute to healthcare affordability.
Biopharmaceutics focuses on understanding the complex interplay between biological systems and pharmaceutical formulations. Biosimilars, being part of this realm, undergo rigorous testing to ensure they meet stringent regulatory standards. As the industry continues to grow, the promise of biosimilars lies in their potential to enhance treatment options, promote competition, and foster innovation in the biopharmaceutical landscape.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Genetic keys and nano locks: Unlocking personalized medicine
Srividya Narayanan, Northeastern University, United States
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico